Tissue-resident memory and circulating T cells are early responders to pre-surgical cancer immunotherapy

Adrienne Luoma(Harvard University), Kai W. Wucherpfennig(Dana-Farber Cancer Institute), Sida Liao(TScan Therapeutics (United States)), Andrew Ferretti(TScan Therapeutics (United States)), Shana Criscitiello(Brigham and Women's Hospital), Jonathan D. Schoenfeld(Brigham and Women's Hospital), Caroline Porter(Broad Institute), Orr Ashenberg(Broad Institute), Nancy Nabilsi(TScan Therapeutics (United States)), Danielle Dionne(Massachusetts Institute of Technology), Eliezer M. Van Allen(Dana-Farber Cancer Institute), Gavin MacBeath(TScan Therapeutics (United States)), Cora A. Ricker(Dana-Farber Cancer Institute), Lauren Gunasti(Brigham and Women's Hospital), Ravindra Uppaluri(Brigham and Women's Hospital), Cagan Gurer(Regeneron (United States)), Jenny Tadros(Massachusetts Institute of Technology), Orit Rozenblatt–Rosen(Broad Institute), Robert I. Haddad(Georgetown University), Yifan Wang(The University of Texas MD Anderson Cancer Center), Aviv Regev(Broad Institute), Yu‐Hui Chen(Dana-Farber Cancer Institute), Shengbao Suo(Guangzhou Experimental Station)
Cited by 376


Related Papers